http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013124401-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
| filingDate | 2011-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2013124401-A |
| titleOfInvention | COMPOSITIONS OF ARIPIPRAZOL AND METHODS OF ITS TRANSDERMAL DELIVERY |
| abstract | 1. A pharmaceutical composition comprising aripiprazole in a dosage form for transdermal delivery. The pharmaceutical composition of claim 1, wherein the aripiprazole is in gel or liquid form. The pharmaceutical composition of claim 1, wherein aripiprazole is present in an amount of from 1 to 20% w / v. 4. The pharmaceutical composition of claim 2, wherein aripiprazole is present in an amount of from 1 to 20% w / v. 5. The pharmaceutical composition of claim 2, wherein the gel comprises a gelling agent in the range of about 0.1 to 5% w / v. 6. The pharmaceutical composition of claim 1, further comprising about 40% N-methyl-2-pyrrolidone, 40% dimethyl sulfoxide, 15% alcohol, and 5% water. The pharmaceutical composition according to claim 1, in the form of a liquid and containing alcohol, glycol, mineral oil and / or vegetable oil. The pharmaceutical composition according to claim 2, wherein the composition is in the form of a gel and further comprises a gelling agent selected from the group consisting of natural polymers, semi-synthetic polymers, synthetic polymers, carboxyvinyl polymers or carbomers, carbopol 940, carbopol 934, carbopol 971, poloxamer, polyacrylamide, polyvinyl alcohol, polyethylene and its copolymers. 9. The pharmaceutical composition of claim 1, wherein the form is a patch for transdermal delivery. The pharmaceutical composition according to claim 1, present in the dosage form of an ointment, cream, emulsion or liposome. The pharmaceutical composition of claim 10, wherein aripiprazole is present in an amount of from 1 to 20% w / v. 12. The pharmaceutical composition of claim 1, further comprising an enhancer. Pharmaceutical |
| priorityDate | 2010-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.